Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 137


Fibrosis progression in paired liver biopsies from HIV/HCV co-infected patients.

Schiavini M, Angeli E, Mainini A, Uberti-Foppa C, Zerbi P, Sagnelli C, Cargnel A, Vago G, Duca PG, Giorgi R, Rizzardini G, Gubertini G.

Hepat Mon. 2011 Jul 1;11(7):525-31.


Liver biopsy in chronic hepatitis C: the experience of 15 Italian wards of infectious diseases.

Sagnelli E, Sagnelli C, Pisaturo MA, Coppola N, Pasquale G, Piccinino F; SIMIT group.

Infez Med. 2012 Mar;20(1):31-6.


Interferon-gamma releasing assay versus tuberculin skin testing for latent tuberculosis infection in targeted screening programs for high risk immigrants.

Orlando G, Merli S, Cordier L, Mazza F, Casazza G, Villa AM, Codecasa L, Negri E, Cargnel A, Ferrarese M, Rizzardini G.

Infection. 2010 Jun;38(3):195-204. doi: 10.1007/s15010-010-0015-2. Epub 2010 Apr 22.


Predictability of sustained virological response to pegylated interferon alpha-2b Plus ribavirin therapy by week-8 viral response in HIV-positive patients with chronic hepatitis C virus infection.

Angeli E, Mainini A, Cargnel A, Uberti-Foppa C, Orani A, Carbone R, Andreoni M, Schiavini M, Giorgi R, Rizzardini G, Gubertini G; ICoS-2 Group.

Curr HIV Res. 2009 Jul;7(4):447-55.


Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjects.

Skowron G, Spritzler JG, Weidler J, Robbins GK, Johnson VA, Chan ES, Asmuth DM, Gandhi RT, Lie Y, Bates M, Pollard RB; NIH/NIAID ACTG 384 Protocol Team and Monogram Biosciences.

J Acquir Immune Defic Syndr. 2009 Mar 1;50(3):250-8. doi: 10.1097/QAI.0b013e3181938faf. Erratum in: J Acquir Immune Defic Syndr. 2009 Jun 1;51(2):238.


Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART.

Saracino A, Gianotti N, Marangi M, Cibelli DC, Galli A, Punzi G, Monno L, Lazzarin A, Angarano G; Mutations, Salvage Study Group.

J Med Virol. 2008 Oct;80(10):1695-706. doi: 10.1002/jmv.21261.


Clinical features of bacterial meningitis in Italy: a multicenter prospective observational study.

Lazzarini L, Toti M, Fabris P, Conti E, Magni G, Mazzotta F, De Lalla F; Mentore Study Group Clinical Investigators.

J Chemother. 2008 Aug;20(4):478-87.


Lopinavir/ritonavir pharmacokinetics in HIV/HCV-coinfected patients with or without cirrhosis.

Micheli V, Regazzi M, Dickinson L, Meraviglia P, Villani P, Khoo SH, Viganò P, Cordier L, Cusato M, Duca P, Orlando G, Rizzardini G, Back DJ, Cargnel A.

Ther Drug Monit. 2008 Jun;30(3):306-13. doi: 10.1097/FTD.0b013e318177209e.


Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction.

Data Collection on Adverse Events of Anti-HIV Drugs Study Group, Sabin CA, d'Arminio Monforte A, Friis-Moller N, Weber R, El-Sadr WM, Reiss P, Kirk O, Mercie P, Law MG, De Wit S, Pradier C, Phillips AN, Lundgren JD.

Clin Infect Dis. 2008 Apr 1;46(7):1101-10. doi: 10.1086/528862.


Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.

D:A:D Study Group, Sabin CA, Worm SW, Weber R, Reiss P, El-Sadr W, Dabis F, De Wit S, Law M, D'Arminio Monforte A, Friis-Møller N, Kirk O, Pradier C, Weller I, Phillips AN, Lundgren JD.

Lancet. 2008 Apr 26;371(9622):1417-26. doi: 10.1016/S0140-6736(08)60423-7. Epub 2008 Apr 2. Erratum in: Lancet. 2008 Jul 26;372(9635):292.


Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilis.

Cicconi P, Cozzi-lepri A, Orlando G, Matteelli A, Girardi E, Degli Esposti A, Moioli C, Rizzardini G, Chiodera A, Ballardini G, Tincati C, d'Arminio Monforte A; I.Co.N.A. Study Group.

Infection. 2008 Feb;36(1):46-53. doi: 10.1007/s15010-007-6300-z. Epub 2008 Jan 29.


Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: the CARe Study.

Santoro MM, Bertoli A, Lorenzini P, Lazzarin A, Esposito R, Carosi G, Di Perri G, Filice G, Moroni M, Rizzardini G, Caramello P, Maserati R, Narciso P, Cargnel A, Antinori A, Perno CF; CARe Study Group.

AIDS Patient Care STDS. 2008 Jan;22(1):7-16.


Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C.

Raffa G, Maimone S, Cargnel A, Santantonio T, Antonucci G, Massari M, Schiavini M, Caccamo G, Pollicino T, Raimondo G.

AIDS. 2007 Oct 18;21(16):2171-5.


Feasibility of assessing autonomic dysregulation at a distance: the case of the HIV-positive patient.

Malacarne M, Cargnel A, Lucini D, Pizzinelli P, Porta A, Pagani M.

Telemed J E Health. 2007 Oct;13(5):557-63.


Genotyping of Pneumocystis jiroveci pneumonia in Italian AIDS patients. Clinical outcome is influenced by dihydropteroate synthase and not by internal transcribed spacer genotype.

Valerio A, Tronconi E, Mazza F, Fantoni G, Atzori C, Tartarone F, Duca P, Cargnel A.

J Acquir Immune Defic Syndr. 2007 Aug 15;45(5):521-8.


Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel.

Soriano V, Puoti M, Sulkowski M, Cargnel A, Benhamou Y, Peters M, Mauss S, Bräu N, Hatzakis A, Pol S, Rockstroh J.

AIDS. 2007 May 31;21(9):1073-89. Review. No abstract available.


High level of genetic heterogeneity in S and P genes of genotype D hepatitis B virus.

De Maddalena C, Giambelli C, Tanzi E, Colzani D, Schiavini M, Milazzo L, Bernini F, Ebranati E, Cargnel A, Bruno R, Galli M, Zehender G.

Virology. 2007 Aug 15;365(1):113-24. Epub 2007 Apr 23.


Natural variability in the HR-1 and HR-2 domains of HIV type 1 gp41 from different clades circulating in Italy.

Razzolini F, Vicenti I, Saladini F, Micheli V, Romano L, Cargnel A, Zazzi M.

AIDS Res Hum Retroviruses. 2007 Apr;23(4):558-63.


The non-peptidic HIV protease inhibitor tipranavir and two synthetic peptidomimetics (TS98 and TS102) modulate Pneumocystis carinii growth and proteasome activity of HEL299 cell line.

Mazza F, Tronconi E, Valerio A, Groettrup M, Kremer M, Tossi A, Benedetti F, Cargnel A, Atzori C.

J Eukaryot Microbiol. 2006;53 Suppl 1:S144-6. No abstract available.


Detection of a proteasome in Pneumocystis carinii and its modulation by specific proteasome inhibitors.

Tronconi E, Mazza F, Valerio A, Rinaudo MT, Piccinini M, Anselmino A, Cargnel A, Atzori C.

J Eukaryot Microbiol. 2006;53 Suppl 1:S142-3. No abstract available.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk